Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian Lord

Showing results (41-50 of 70) with videos related to

Pageof 7
Sort By:
Bioorganic & Medicinal Chemistry Letters|January 3, 2009
Novel imidazole-based histamine H3 antagonistsJill A Jablonowski, Kiev S Ly, Michael Bogenstaetter, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 14, 2009
Blockade of orexin-1 receptors attenuates orexin-2 receptor antagonism-induced sleep promotion in the ratChristine Dugovic, Jonathan E Shelton, Leah E Aluisio, et al.
ACS Medicinal Chemistry Letters|April 17, 2024
Structure-Based Optimization of Selective and Brain Penetrant CK1δ Inhibitors for the Treatment of Circadian DisruptionsStefan McCarver, Luke Hanna, Andrew Samant, et al.
Bioorganic & Medicinal Chemistry Letters|September 17, 2010
Indole- and benzothiophene-based histamine H3 antagonistsAlejandro Santillan, Kelly J McClure, Brett D Allison, et al.
ACS Medicinal Chemistry Letters|March 21, 2019
Discovery of Imidazo[1,2-<i>a</i>]pyrazines and Pyrazolo[1,5-<i>c</i>]pyrimidines as TARP γ-8 Selective AMPAR Negative ModulatorsBrad M Savall, Dongpei Wu, Devin M Swanson, et al.
Psychopharmacology|November 19, 2010
JNJ-39220675, a novel selective histamine H3 receptor antagonist, reduces the abuse-related effects of alcohol in ratsRuggero Galici, Amir H Rezvani, Leah Aluisio, et al.
European Journal of Medicinal Chemistry|July 7, 2009
Heterocyclic replacement of the central phenyl core of diamine-based histamine H3 receptor antagonistsDevin M Swanson, Chandra R Shah, Brian Lord, et al.
Psychopharmacology|December 3, 2009
In vitro and in vivo characterization of JNJ-31020028 (N-(4-{4-[2-(diethylamino)-2-oxo-1-phenylethyl]piperazin-1-yl}-3-fluorophenyl)-2-pyridin-3-ylbenzamide), a selective brain penetrant small molecule antagonist of the neuropeptide Y Y(2) receptorJames R Shoblock, Natalie Welty, Diane Nepomuceno, et al.
European Journal of Pharmacology|September 4, 2007
Pharmacological characterization of JNJ-28583867, a histamine H(3) receptor antagonist and serotonin reuptake inhibitorAnn J Barbier, Leah Aluisio, Brian Lord, et al.
Journal of Medicinal Chemistry|August 14, 2020
Design, Synthesis, and Preclinical Evaluation of 3-Methyl-6-(5-thiophenyl)-1,3-dihydro-imidazo[4,5-<i>b</i>]pyridin-2-ones as Selective GluN2B Negative Allosteric Modulators for the Treatment of Mood DisordersChrista C Chrovian, Akinola Soyode-Johnson, Brice Stenne, et al.
Pageof 7

Showing results (41-50 of 70) with videos related to

Sort By:
Pageof 7
Bioorganic & Medicinal Chemistry Letters|January 3, 2009
Novel imidazole-based histamine H3 antagonistsJill A Jablonowski, Kiev S Ly, Michael Bogenstaetter, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 14, 2009
Blockade of orexin-1 receptors attenuates orexin-2 receptor antagonism-induced sleep promotion in the ratChristine Dugovic, Jonathan E Shelton, Leah E Aluisio, et al.
ACS Medicinal Chemistry Letters|April 17, 2024
Structure-Based Optimization of Selective and Brain Penetrant CK1δ Inhibitors for the Treatment of Circadian DisruptionsStefan McCarver, Luke Hanna, Andrew Samant, et al.
Bioorganic & Medicinal Chemistry Letters|September 17, 2010
Indole- and benzothiophene-based histamine H3 antagonistsAlejandro Santillan, Kelly J McClure, Brett D Allison, et al.
ACS Medicinal Chemistry Letters|March 21, 2019
Discovery of Imidazo[1,2-<i>a</i>]pyrazines and Pyrazolo[1,5-<i>c</i>]pyrimidines as TARP γ-8 Selective AMPAR Negative ModulatorsBrad M Savall, Dongpei Wu, Devin M Swanson, et al.
Psychopharmacology|November 19, 2010
JNJ-39220675, a novel selective histamine H3 receptor antagonist, reduces the abuse-related effects of alcohol in ratsRuggero Galici, Amir H Rezvani, Leah Aluisio, et al.
European Journal of Medicinal Chemistry|July 7, 2009
Heterocyclic replacement of the central phenyl core of diamine-based histamine H3 receptor antagonistsDevin M Swanson, Chandra R Shah, Brian Lord, et al.
Psychopharmacology|December 3, 2009
In vitro and in vivo characterization of JNJ-31020028 (N-(4-{4-[2-(diethylamino)-2-oxo-1-phenylethyl]piperazin-1-yl}-3-fluorophenyl)-2-pyridin-3-ylbenzamide), a selective brain penetrant small molecule antagonist of the neuropeptide Y Y(2) receptorJames R Shoblock, Natalie Welty, Diane Nepomuceno, et al.
European Journal of Pharmacology|September 4, 2007
Pharmacological characterization of JNJ-28583867, a histamine H(3) receptor antagonist and serotonin reuptake inhibitorAnn J Barbier, Leah Aluisio, Brian Lord, et al.
Journal of Medicinal Chemistry|August 14, 2020
Design, Synthesis, and Preclinical Evaluation of 3-Methyl-6-(5-thiophenyl)-1,3-dihydro-imidazo[4,5-<i>b</i>]pyridin-2-ones as Selective GluN2B Negative Allosteric Modulators for the Treatment of Mood DisordersChrista C Chrovian, Akinola Soyode-Johnson, Brice Stenne, et al.
Pageof 7